NEUROPATHIES PERIPHERIQUES DE LA MACROGLOBULINEMIE DE WALDENSTROEMDELLAGI K; BROUET JC.1982; ACTUAL. HEMATOL.; ISSN 0567-8757; FRA; DA. 1982; NO 15; PP. 211-216; BIBL. 11 REF.Article

CROSS-IDIOTYPIC ANTIGENS AMONG MONOCLONAL IMMUNOGLOBULIN M FROM PATIENTS WITH WALDENSTROEM'S MACROGLOBULINEMIA AND POLYNEUROPATHYDELLAGI K; BROUET JC; DANON F et al.1979; J. CLIN. INVEST.; USA; DA. 1979; VOL. 64; NO 5; PP. 1530-1534; BIBL. 22 REF.Article

Alteration of vimentin intermediate filaments expression during differentiation of HL₆₀ and U₉₃₇ human leukemic cell lines = Modification de l'expression des filaments intermédiaires de vimentine au cours de la différenciation des lignées de cellules leucémiques humaines HL60 et U937DELLAGI, K; BROUET, J.-C.Leukemia research. 1984, Vol 8, Num 4, pp 611-616, issn 0145-2126Article

Effects of tropism and virulence of Leishmania parasites on cytokine production by infected human monocytesMEDDEB-GARNAOUI, A; ZRELLI, H; DELLAGI, K et al.Clinical and experimental immunology (Print). 2009, Vol 155, Num 2, pp 199-206, issn 0009-9104, 8 p.Article

Colloque : Chikungunya et autres arboviroses en milieu tropical, Saint-Gilles, La Réunion, 3-4 décembre 2007BRÜCKER, G; DELLAGI, K; GAUZERE, B.-A et al.Bulletin de la Société de pathologie exotique. 2007, Vol 100, Num 5, issn 0037-9085, 55 p.Conference Proceedings

Les leishmanioses : un modèle d'étude des interactions hôte-parasite ; implications pour la maladie humaine = Leishmaniases: models for host-parasite relationship: consequences for the human diseaseLOUZIR, H; DELLAGI, K.Annales de l'Institut Pasteur. Actualités. 1999, Vol 10, Num 1, pp 67-80, issn 0924-4204Article

Protein S deficiency and antibodies to protein S in patients with Behcet's diseaseGUERMAZI, S; HAMZA, M; DELLAGI, K et al.Thrombosis research. 1997, Vol 86, Num 3, pp 197-204, issn 0049-3848Article

Genomic structure and characterisation of the promoter region of the human IL-18 geneEL KARES, R; ABDELHAK, S; DELLAGI, K et al.Archives de l'Institut Pasteur de Tunis. 2000, Vol 77, Num 1-4, pp 55-58, issn 0020-2509, 4 p.Article

Antivimentin autoantibodies in angioimmunoblastic lymphadenopathyDELLAGI, K; BROUET, J.-C; SELIGMANN, M et al.The New England journal of medicine. 1984, Vol 310, Num 4, pp 215-218, issn 0028-4793Article

Chondrome nasal associé à une maladie d'Ollier. A propos d'un cas observé à l'Institut Gustave-Roussy = Nasal chondroma associated with Ollier's disease. A case reportDELLAGI, K; MICHEAU, C; ESTELIN, R et al.Annales d'oto-laryngologie et de chirurgie cervico-faciale. 1985, Vol 102, Num 7, pp 537-541, issn 0003-438XArticle

Organisation du cytosquelette des filaments intermédiaires dans les cellules sanguinesDELLAGI, K; VAINCHENKER, W; BROUET, J. C et al.Actualités hématologiques. 1983, Vol 17, pp 51-56, issn 0567-8757Article

Leishmania major induces deactivation of extracellular signal regulated kinases 2 in human U937 macrophage like cellsGUIZANI-TABBANE, L; OUNI, I; SASSI, A et al.Archives de l'Institut Pasteur de Tunis. 2000, Vol 77, Num 1-4, pp 45-50, issn 0020-2509, 6 p.Article

A model to study the effects of a viral inactivator (β-propiolactone) on DNA ligation and gene expression in E. coli and Cos cellsFATHALLAH, D. M; ZERRIA, K; BARBOUCHE, M. R et al.Vaccine. 1999, Vol 17, Num 1, pp 95-98, issn 0264-410XArticle

Syndrome hémorragique et déficit isolé en α2 antiplasmine : A propos d'un cas = Bleeding syndrom and isolated α2 antiplasmin deficiency. A case reportGUERMAZI, S; KHELIF, A; CONARD, J et al.Pathologie et biologie. 1997, Vol 45, Num 6, pp 483-486, issn 0369-8114Article

Guérison d'une hépatite chronique active par immunoglobulines intraveineuses à fortes doses au cours d'une agammaglobulinémie = Successful reversal of chronic active hepatitis by giving an agammaglobulinemic patient intravenous immunoglobulinsBEJAOUI, M; GHARBI, A; BOUGUERRA, A et al.Archives de pédiatrie (Paris). 1994, Vol 1, Num 2, pp 158-161, issn 0929-693XArticle

Human monoclonal IgMs with anti-Mycoplasma pneumoniae antibody activityBEN AISSA-FENNIRA, F; BENAMMAR-ELGAAIED, A; DELLAGI, K et al.Archives de l'Institut Pasteur de Tunis. 2003, Vol 80, Num 1-4, pp 3-8, issn 0020-2509, 6 p.Article

Maladie de willebrand de type 2B et pseudomaladie de willebrand de type 2B ; à propos de trois observations = Type 2B and pseudo type 2B von willebrand disease; a report of three casesGUERMAZI, S; CONARD, J; SAMAMA, M. M et al.Pathologie et biologie. 2006, Vol 54, Num 3, pp 159-165, issn 0369-8114, 7 p.Article

Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factorBEN ACHOUR, Y; CHENIK, M; LOUZIR, H et al.Infection and immunity. 2002, Vol 70, Num 7, pp 3576-3585, issn 0019-9567Article

Myo-épithéliome (ou adénome à cellules myo-épithéliales): à propos d'un cas = Myoepithelioma of the parotid. One case reportVO-NGOC, H; DELLAGI, K; MARANDAS, P et al.Annales de pathologie (Paris). 1994, Vol 14, Num 2, pp 112-115, issn 0242-6498Article

Molecular cloning of a novel human hsp70 from a B cell line and its assignment to chromosome 5FATHALLAH, D. M; CHERIF, D; DELLAGI, K et al.The Journal of immunology (1950). 1993, Vol 151, Num 2, pp 810-813, issn 0022-1767Article

Detection of cross-reactive determinants shared by human monoclonal IgM reacting with myelin-associated glycoproteinSCHMITT, C; DELLAGI, K; MIHAESCO, E et al.The Journal of immunology (1950). 1987, Vol 138, Num 5, pp 1442-1446, issn 0022-1767Article

Depletion of peritoneal CD5⁺ B cells has no effect on the course of Leishmania major infection in susceptible and resistant miceBABAI, B; LOUZIR, H; CAZENAVE, P.-A et al.Clinical and experimental immunology (Print). 1999, Vol 117, Num 1, pp 123-129, issn 0009-9104Article

Neuropathie périphérique de la macroglobulinémie de Waldenström: activité anticorps de l'immunoglobulinémie M monoclonale dirigée contre la vimentine = The peripheric neuropathy in Waldenström's disease: antibody activity of the monoclonal IgM against vimentineDELLAGI, K; CHEDRU, F; CLAUVEL, J. P et al.La Presse médicale (1983). 1984, Vol 13, Num 19, pp 1199-1201, issn 0755-4982Article

Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB/c mice against a virulent challenge with Leishmania majorCHENIK, M; LOUZIR, H; KSONTINI, H et al.Vaccine. 2006, Vol 24, Num 14, pp 2521-2529, issn 0264-410X, 9 p.Article

Déficit immunitaire primitif par défaut d'expression des antigènes HLA de classe II: neuf observations tunisiennes = Major histocompatibility class II antigen deficiency: nine new Tunisian casesBEJAOUI, M; BARBOUCHE, M. R; MELLOULI, F et al.Archives de pédiatrie (Paris). 1998, Vol 5, Num 10, pp 1089-1093, issn 0929-693XArticle